3 latest FDA approvals

Here are the three latest drugs or medical devices approved by the Food and Drug Administration this week.

Advertisement

1. Tremfya is a biologic drug used to treat psoriasis.

2. Endari is intended to treat serious complications associated with sickle cell disease and represents the first approved treatment for the condition in nearly two decades.

3. Blincyto is used to treat pediatric and adult patients with a specific type of acute lymphoblastic leukemia.

More articles on supply chain:

7 must-reads for supply chain leaders this week
House passes FDA user fee reauthorization bill
Are outcomes-based drug contracts effective? 5 thoughts

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.